Cargando…
Precision Medicine in Soft Tissue Sarcoma Treatment
Soft tissue sarcoma (STS) is a rare component of malignant diseases. STS includes various histological subtypes, and there are some important differences among the different histological subtypes regarding the mutation profile and sensitivity to antitumor agents. Many clinical trials of STS incorpor...
Autores principales: | Nakano, Kenji, Takahashi, Shunji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017346/ https://www.ncbi.nlm.nih.gov/pubmed/31963219 http://dx.doi.org/10.3390/cancers12010221 |
Ejemplares similares
-
Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas
por: Nakano, Kenji, et al.
Publicado: (2018) -
Translocation-Related Sarcomas
por: Nakano, Kenji, et al.
Publicado: (2018) -
Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib Responders
por: Nakano, Kenji, et al.
Publicado: (2019) -
Genomic-guided precision therapy for soft tissue sarcoma
por: Chen, Hsing-Wu, et al.
Publicado: (2020) -
Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis
por: Nakano, Kenji, et al.
Publicado: (2016)